Searched for
UDCA
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...- Zydus Saroglitazar shows positive Phase 3 results in rare liver disease PBC, US filing planned in 2026Zydus Therapeutics reveals encouraging outcomes from Saroglitazar's clinical trial. The drug targets Primary Biliary Cholangitis. The EPICS...
- Rocket Returns: This Madhusudhan Kela and Sunil Singhania-owned smallcap stock has rallied 45% since April QIPShilpa Medicare, held by Madhusudhan Kela and Sunil Singhania, has returned 45% since its QIP allotment four months ago. Singhania's Abakku...
- Shilpa Medicare completes phase-3 trial of novel therapy against nonalcoholic fatty liver disease, shares gainShilpa Medicare's shares surged 6.40% on BSE following the successful phase-3 clinical trials of Nor Ursodeoxycholic Acid tablets for Nonal...
- India imposes anti-dumping duty on ursodiolAn industry expert said China had been “unfairly dumping” the chemical, which had brought down its local price from $350 a kg in 2018 to $1...
- Sloth bear poaching for aphrodisiacs: Madhya Pradesh constitutes SITMadhya Pradesh forest department has constituted a special investigation team (SIT) to probe the role of a global syndicate behind poaching...
Load More